A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Keytruda
Related studies linked through entity extraction aliases.
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE3
Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trial of TB511 in Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Study of the Efficacy and Safety of BCD-201 and Keytruda in Subjects With Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenvatinib Combined Anti-PD1 Antibody for the Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Axitinib Therapy Management Study
- Status
- WITHDRAWN
- Phase
- N/A
OH2 Injection in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1